Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learning.
endocannabinoids
fear conditioning
fear extinction
posttraumatic stress disorder
Journal
Depression and anxiety
ISSN: 1520-6394
Titre abrégé: Depress Anxiety
Pays: United States
ID NLM: 9708816
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
04
05
2021
received:
01
02
2021
accepted:
07
05
2021
pubmed:
22
6
2021
medline:
25
2
2023
entrez:
21
6
2021
Statut:
ppublish
Résumé
The endocannabinoid system is gaining increasing attention as a favorable target for improving posttraumatic stress disorder (PTSD) treatments. Exposure therapy is the gold-standard treatment for PTSD, and fear extinction learning is a key concept underlying successful exposure. This study examined the role of genetic endocannabinoid polymorphisms in a fear extinction paradigm with PTSD compared to healthy participants (N = 220). Participants provided saliva for genotyping, completed a fear conditioning and extinction task, with blood samples taken before and after the task (n = 57). Skin conductance was the outcome and was analyzed using mixed models. Results for cannabinoid receptor type 1 polymorphisms suggested that minor alleles of rs2180619 and rs1049353 were associated with poorer extinction learning in PTSD participants. The minor allele of the fatty acid amide hydrolase (FAAH) polymorphism rs324420 was associated with worse extinction in PTSD participants. Subanalysis of healthy participants (n = 57) showed the FAAH rs324420 genotype effect was dependent on plasma arachidonoyl ethanolamide (AEA) level, but not oleoylethanolamide or 2-arachidonoyl glycerol. Specifically, higher but not lower AEA levels in conjunction with the minor allele of FAAH rs324420 were associated with better extinction learning. These findings provide translational evidence that cannabinoid receptor 1 and AEA are involved in extinction learning in humans. FAAH rs324420's effect on fear extinction is moderated by AEA plasma level in healthy controls. These findings imply that FAAH inhibitors may be effective for targeting anxiety in PTSD, but this effect needs to be explored further in clinical populations.
Sections du résumé
BACKGROUND
The endocannabinoid system is gaining increasing attention as a favorable target for improving posttraumatic stress disorder (PTSD) treatments. Exposure therapy is the gold-standard treatment for PTSD, and fear extinction learning is a key concept underlying successful exposure.
METHODS
This study examined the role of genetic endocannabinoid polymorphisms in a fear extinction paradigm with PTSD compared to healthy participants (N = 220). Participants provided saliva for genotyping, completed a fear conditioning and extinction task, with blood samples taken before and after the task (n = 57). Skin conductance was the outcome and was analyzed using mixed models.
RESULTS
Results for cannabinoid receptor type 1 polymorphisms suggested that minor alleles of rs2180619 and rs1049353 were associated with poorer extinction learning in PTSD participants. The minor allele of the fatty acid amide hydrolase (FAAH) polymorphism rs324420 was associated with worse extinction in PTSD participants. Subanalysis of healthy participants (n = 57) showed the FAAH rs324420 genotype effect was dependent on plasma arachidonoyl ethanolamide (AEA) level, but not oleoylethanolamide or 2-arachidonoyl glycerol. Specifically, higher but not lower AEA levels in conjunction with the minor allele of FAAH rs324420 were associated with better extinction learning.
CONCLUSIONS
These findings provide translational evidence that cannabinoid receptor 1 and AEA are involved in extinction learning in humans. FAAH rs324420's effect on fear extinction is moderated by AEA plasma level in healthy controls. These findings imply that FAAH inhibitors may be effective for targeting anxiety in PTSD, but this effect needs to be explored further in clinical populations.
Substances chimiques
Cannabinoids
0
Endocannabinoids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1087-1099Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Association.
Bach, D., & Friston, K. J. (2013). Model-based analysis of skin conductance responses: Towards causal models in. psychophysiology. Psychophysiology, 50(1), 15-22.
Bach, D., Friston, K. J., & Dolan, R. J. (2013). An improved algorithm for model-based analysis of evoked skin conductance responses. Biological Psychology, 94(3), 490-497.
Bach, D., & Melinscak, F. (2020). Psychophysiological modelling and the measurement of fear conditioning. Behaviour Research and Therapy, 127, 103576.
Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289-300.
Bowers, M. E., & Ressler, K. J. (2015). Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention. Neuropsychopharmacology, 40(3), 688-700.
Briscione, M. A., Jovanovic, T., & Norrholm, S. D. (2014). Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Frontiers in Psychiatry, 5, 88.
Crombie, K. M., Leitzelar, B. N., Brellenthin, A. G., Hillard, C. J., & Koltyn, K. F. (2019). Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD. Biological Psychology, 145, 1-7.
Demers, C., Conley, E. D., Bogdan, R., & Hariri, A. R. (2015). Interactions between anandamide and corticotropin-releasing factor signaling modulate human amygdala function and risk for anxiety disorders: An imaging genetics strategy for modeling molecular interactions. Biological Psychiatry, 80(5), 356-362.
de Roon-Cassini, T. A., Stollenwerk, T. M., Beatka, M., & Hillard, C. J. (2020). Meet your stress management professionals: The endocannabinoids. Trends in Molecular Medicine, 26(10), 953-968.
Dincheva, I., Drysdale, A. T., Hartley, C. A., Johnson, D. C., Jing, D., King, E. C., Ra, S., Gray, J. M., Yang, R., DeGruccio, A. M., Huang, C., Cravatt, B. F., Glatt, C. E., Hill, M. N., Casey, B. J., & Lee, F. S. (2015). FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nature Communications, 6, 6395.
Dlugos, A., Childs, E., Stuhr, K. L., Hillard, C. J., & de Wit, H. (2012). Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology, 37(11), 2416-2427.
Dunsmoor, J. E., Otto, A. R., & Phelps, E. A. (2017). Stress promotes generalization of older but not recent threat memories. Proceedings of the National Academy of Sciences of the United States of America, 114(34), 9218-9223.
Ganon-Elazar, E., & Akirav, I. (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Journal of Neuroscience, 29(36), 11078-11088.
Gee, D. G., Fetcho, R. N., Jing, D., Li, A., Glatt, C. E., Drysdale, A. T., Cohen, A. O., Dellarco, D. V., Yang, R. R., Dale, A. M., Jernigan, T. L., Lee, F. S., & Casey, B. J. (2016). Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species. Proceedings of the National Academy of Sciences of the United States of America, 113(16), 4500-4505.
Glover, E. M., Jovanovic, T., Mercer, K. B., Kerley, K., Bradley, B., Ressler, K. J., & Norrholm, S. D. (2012). Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biological Psychiatry, 72(1), 19-24.
Glover, E. M., Jovanovic, T., & Norrholm, S. D. (2015). Estrogen and extinction of fear memories: Implications for posttraumatic stress disorder treatment. Biological Psychiatry, 78(3), 178-185.
Gogos, A., Ney, L. J., Seymour, N., Van Rheenen, T., & Felmingam, K. L. (2019). Sex differences in schizophrenia, bipolar disorder and PTSD: Are gonadal hormones the link? British Journal of Pharmacology, 176(21), 4119-4135, 176, 4119-4135.
Graham, B. M., Callaghan, B. L., & Richardson, R. (2014). Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders. Behaviour Research and Therapy, 62, 3-16.
Grillon, C. (2002). Associative learning deficits increase symptoms of anxiety in humans. Biological Psychiatry, 51(11), 851-858.
Grillon, C., & Morgan, C. A. (1999). Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. Journal of Abnormal Psychology, 108(1), 134-142.
Grillon, C., Pine, D. S., Lissek, S., Rabin, S., Bonne, O., & Vythilingam, M. (2009). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biological Psychiatry, 66(1), 47-53.
Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., Nikas, S. P., Makriyannis, A., Poulton, R., Patel, S., Hariri, A. R., Caspi, A., Moffitt, T. E., Kunos G., & Holmes, A. (2013). Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry, 18(7), 813-823.
Hammoud, M. Z., Peters, C., Hatfield, J. R. B., Gorka, S. M., Phan, K. L., Milad, M. R., & Rabinak, C. A. (2019). Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans. Neuropsychopharmacology, 44(10), 1769-1777.
Hariri, A. R., Gorka, A., Hyde, L. W., Kimak, M., Halder, I., Ducci, F., Ferrell, R. E., Goldman, D., & Manuck, S. B. (2009). Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biological Psychiatry, 66(1), 9-16.
Harnett, N. G., Ference, E. W., 3rd, Wood, K. H., Wheelock, M. D., Knight, A. J., & Knight, D. C. (2018). Trauma exposure acutely alters neural function during Pavlovian fear conditioning. Cortex, 109, 1-13.
Harris, B. N., Hohman, Z. P., Campbell, C. M., King, K. S., & Tucker, C. A. (2019). FAAH genotype, CRFR1 genotype, and cortisol interact to predict anxiety in an aging, rural Hispanic population: A project FRONTIER study. Neurobiology of Stress, 10, 100154.
Hartley, N. D., Gunduz-Cinar, O., Halladay, L., Bukalo, O., Holmes, A., & Patel, S. (2016). 2-arachidonoylglycerol signaling impairs short-term fear extinction. Translational Psychiatry, 6, e749.
Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Guilford Press.
Heitland, I., Klumpers, F., Oosting, R. S., Evers, D. J., Leon Kenemans, J., & Baas, J. M. (2012). Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. Translational Psychiatry, 2, e162.
Hill, M. N., Bierer, L. M., Makotkine, I., Golier, J. A., Galea, S., McEwen, B. S., Hillard, C. J., & Yehuda, R. (2013). Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology, 38(12), 2952-2961.
Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2018). Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder. Neuropsychopharmacology, 43(1), 80-102.
Jovanovic, T., Kazama, A., Bachevalier, J., & Davis, M. (2012). Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology, 62(2), 695-704.
Jovanovic, T., Norrholm, S. D., Blanding, N. Q., Davis, M., Duncan, E., Bradley, B., & Ressler, K. J. (2010). Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety, 27(3), 244-251.
Kamprath, K., Marsicano, G., Tang, J., Monory, K., Bisogno, T., Di Marzo, V., Lutz, B., & Wotjak, C. T. (2006). Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. Journal of Neuroscience, 26(25), 6677-6686.
Lazary, J., Eszlari, N., Juhasz, G., & Bagdy, G. (2016). Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma. European Neuropsychopharmacology, 26(6), 1020-1028.
Lazary, J., Lazáry, A., Gonda, X., Benko, A., Molnar, E., Hunyady, L., Juhasz, G., & Bagdy, G. (2009). Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with5-HTTLPRaffect the anxious phenotype. Promoter Variants of the Cannabinoid Receptor 1 Gene (CNR1) in Interaction With 5-HTTLPR Affect the Anxious Phenotype, 150B, 1118-1127.
Lebron-Milad, K., Graham, B. M., & Milad, M. R. (2012). Low estradiol levels: A vulnerability factor for the development of posttraumatic stress disorder. Biological Psychiatry, 72, 6-7.
Levy-Gigi, E., Szabo, C., Richter-Levin, G., & Kéri, S. (2015). Reduced hippocampal volume is associated with overgeneralization of negative context in individuals with PTSD. Neuropsychology, 29(1), 151-161.
Li, S., & Graham, B. M. (2017). Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. The Lancet Psychiatry, 4(1), 73-82.
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016). From phytocannabinoids to cannabinoid receptors and endocannabinoids: Pleiotropic physiological and pathological roles through complex pharmacology. Physiological Reviews, 96(4), 1593-1659.
Lissek, S., & van Meurs, B. (2015). Learning models of PTSD: Theoretical accounts and psychobiological evidence. International Journal of Psychophysiology, 98(3, Part, 2, 594-605.
Lonsdorf, T. B., & Kalisch, R. (2011). A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment. Translational Psychiatry, 1, e41.
Lonsdorf, T. B., Menz, M. M., Andreatta, M., Fullana, M. A., Golkar, A., Haaker, J., Heitland, I., Hermann, A., Kuhn, M., Kruse, O., Meir Drexler, S., Meulders, A., Nees, F., Pittig, A., Richter, J., Romer, S., Shiban, Y., Schmitz, A., Straube, B., … Merz, C. J. (2017). Don't fear 'fear conditioning': Methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear. Neuroscience and Biobehavioral Reviews, 77, 247-285.
Lovibond, S. H., & Lovibond, P. F. (1995). Depression Anxiety Stress Scales (DASS). Psychology Foundation.
Lu, A. T., Ogdie, M. N., Jarvelin, M. R., Moilanen, I. K., Loo, S. K., McCracken, J. T., McGough, J. J., Yang, M. H., Peltonen, L., Nelson, S. F., Cantor, R. M., & Smalley, S. L. (2008). Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. American Journal of Medical Genetics, 147B(8), 1488-1494.
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisognok, T., Rammes, G., Casciok, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzok, V., & Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530-534.
Mayo, L. M., Asratian, A., Linde, J., Holm, L., Natt, D., Augier, G., Stensson, N., Vecchiarelli, H. A., Balsevich, G., Aukema, R. J., Ghafouri, B., Spagnolo, P. A., Lee, F. S., Hill, M. N., & Heilig, M. (2018). Protective effects of elevated anandamide on stress and fear-related behaviors: Translational evidence from humans and mice. Molecular Psychiatry, 25(5), 993-1005.
Mayo, L. M., Asratian, A., Lindé, J., Morena, M., Haataja, R., Hammar, V., Augier, G., Hill, M. N., & Heilig, M. (2019). Elevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: A randomized, controlled experimental medicine trial. Biological Psychiatry, 87(6), 538-547.
Merz, C. J., Kinner, V. L., & Wolf, O. T. (2018). Let's talk about sex … differences in human fear conditioning. Current Opinion in Behavioral Sciences, 23, 7-12.
Milad, M. R., Quinn, B. T., Pitman, R. K., Orr, S. P., Fischl, B., & Rauch, S. L. (2005). Thickness of ventromedial prefrontal cortex in humans is correlated with extinction memory. Proceedings of the National Academy of Sciences USA, 102(30), 10706-10711.
Milad, M. R., & Quirk, G. J. (2012). Fear extinction as a model for translational neuroscience: ten years of progress. Annual Review of Psychology, 63, 129-151.
Milad, M. R., Zeidan, M. A., Contero, A., Pitman, R. K., Klibanski, A., Rauch, S. L., & Goldstein, J. M. (2010). The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience, 168(3), 652-658.
Moore, S. R. (2017). Commentary: What is the case for candidate gene approaches in the era of high-throughput genomics? A response to Border and Keller (2017). Journal of Child Psychology and Psychiatry, 58(3), 331-334.
Morena, M., Berardi, A., Colucci, P., Palmery, M., Trezza, V., Hill, M. N., & Campolongo, P. (2018). Enhancing endocannabinoid neurotransmission augments the efficacy of extinction training and ameliorates traumatic stress-induced behavioral alterations in rats. Neuropsychopharmacology, 43(6), 1284-1296.
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016). Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology, 41(1), 80-102.
Morey, R. A., Dunsmoor, J. E., Haswell, C. C., Brown, V. M., Vora, A., Weiner, J., Stjepanovic, D., Wagner, H. R., Brancu, M., Marx, C. E., Naylor, J. C., Van Voorhees, E., Taber, K. H., Beckham, J. C., Calhoun, P. S., Fairbank, J. A., Szabo, S. T., LaBar, K. S., & Workgroup, V. A. M.-A. M. (2015). Fear learning circuitry is biased toward generalization of fear associations in posttraumatic stress disorder. Translational Psychiatry, 5(12), e700.
Mota, N., Sumner, J. A., Lowe, S. R., Neumeister, A., Uddin, M., Aiello, A. E., Wildman, D. E., Galea, S., Koenen, K. C., & Pietrzak, R. H. (2015). The rs1049353 polymorphism in the CNR1 gene interacts with childhood abuse to predict posttraumatic threat symptoms. The Journal of Clinical Psychiatry, 76(12), e1622-e1623.
Ney, L. J., Akhurst, J., Bruno, R., Laing, P. A. F., Matthews, A., & Felmingham, K. L. (2021). Dopamine, endocannabinoids and their interaction in fear extinction and negative affect in PTSD. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 105, 110118.
Ney, L. J., Felmingham, K. L., Matthews, A., Bruno, R., & Nichols, D. (2020). Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva. Journal of Chromatography B, 1152, 1152.
Ney, L. J., Gogos, A., Ken Hsu, C.-M., & Felmingham, K. L. (2019). An alternative theory for hormone effects on sex differences in PTSD: The role of heightened sex hormones during trauma. Psychoneuroendocrinology, 109, 104416.
Ney, L. J., Laing, P. A. F., Steward, T., Zuj, D. V., Dymond, S., & Felmingham, K. (2020). Inconsistent analytic strategies reduce robustness in fear extinction via skin conductance response. Psychophysiology, 57(11), e13650.
Ney, L. J., Matthews, A., Bruno, R., & Felmingham, K. L. (2018). Modulation of the endocannabinoid system by sex hormones: Implications for posttraumatic stress disorder. Neuroscience and Biobehavioral Reviews, 94, 302-320.
Ney, L. J., Matthews, A., Bruno, R., & Felmingham, K. L. (2019). Cannabinoid interventions for PTSD: Where to next? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 93, 124-140.
Ney, L. J., Stone, C., Nichols, D., Felmingam, K. L., Bruno, R., & Matthews, A. (2021). Endocannabinoid reactivity to acute stress: Investigation of the relationship between salivary and plasma levels. Biological Psychology, 159, 159.
Ney, L. J., Vicario, C. M., Nitsche, M. A., & Felmingham, K. L. (2021). Timing matters: Transcranial direct current stimulation after extinction learning impairs subsequent fear extinction retention. Neurobiology of Learning and Memory, 177, 177.
Ney, L. J., Wade, M., Reynolds, A., Zuj, D. V., Dymond, S., Matthews, A., & Felmingham, K. L. (2018). Critical evaluation of current data analysis strategies for psychophysiological measures of fear conditioning and extinction in humans. International Journal of Psychophysiology, 134, 95-107.
Orr, S. P., Metzger, L. J., Lasko, N. B., Macklin, M. L., Peri, T., & Pitman, R. K. (2000). De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder. Journal of Abnormal Psychology, 109(2), 290-298.
Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021). Cannabis sativa: Interdisciplinary strategies and avenues for medical and commercial progression outside of CBD and THC. Biomedicines, 9(3), 234.
Peri, T., Ben-Shakhar, G., Orr, S. P., & Shalev, A. Y. (2000). Psychophysiologic assessment of aversive conditioning in posttraumatic stress disorder. Biological Psychiatry, 47(6), 512-519.
Pulley, J. M., Denny, J. C., Peterson, J. F., Bernard, G. R., Vnencak-Jones, C. L., Ramirez, A. H., Delaney, J. T., Bowton, E., Brothers, K., Johnson, K., Crawford, D. C., Schildcrout, J., Masys, D. R., Dilks, H. H., Wilke, R. A., Clayton, E. W., Shultz, E., Laposata, M., McPherson, J., … Roden, D. M. (2012). Operational implementation of prospective genotyping for personalized medicine: The design of the Vanderbilt PREDICT project. Clinical Pharmacology and Therapeutics, 92(1), 87-95.
Rabinak, C. A., Angstadt, M., Sripada, C. S., Abelson, J. L., Liberzon, I., Milad, M. R., & Phan, K. L. (2013). Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology, 64, 396-402.
Rothbaum, B. O., & Davis, M. (2003). Applying learning principles to the treatment of post-trauma reactions. Annals of the New York Academy of Sciences, 1008, 112-121.
Ruiz-Contreras, A. E., Carrillo-Sánchez, K., Ortega-Mora, I., Barrera-Tlapa, M. A., Román-López, T. V., Rosas-Escobar, C. B., Flores-Barrera, L., Caballero-Sánchez, U., Muñoz-Torres, Z., Romero-Hidalgo, S., Hernández-Morales, S., González-Barrios, J. A., Vadillo-Ortega, F., Méndez-Díaz, M., Aguilar-Roblero, R., & Prospéro-García, O. (2014). Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene. Genes, Brain and Behavior, 13(2), 173-178.
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction, 88, 791-804.
Schmitz, A., & Grillon, C. (2012). Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nature Protocols, 7(3), 527-532.
Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002). A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proceedings of the National Academy of Sciences USA, 99(12), 8394-8399.
Spagnolo, P. A., Ramchandani, V. A., Schwandt, M. L., Kwako, L. E., George, D. T., Mayo, L. M., Hillard, C. J., & Heilig, M. (2016). FAAH gene variation moderates stress response and symptom severity in patients with posttraumatic stress disorder and comorbid alcohol dependence. Alcoholism, Clinical and Experimental Research, 40(11), 2426-2434.
Stark, E. A., Parsons, C. E., Van Hartevelt, T. J., Charquero-Ballester, M., McManners, H., Ehlers, A., Stein, A., & Kringelbach, M. L. (2015). Post-traumatic stress influences the brain even in the absence of symptoms: A systematic, quantitative meta-analysis of neuroimaging studies. Neuroscience and Biobehavioral Reviews, 56, 207-221.
Vrana, S., & Lauterbach, D. (1994). Prevalence of traumatic events and post-traumatic psychological symptoms in a nonclinical sample of college students. Journal of Traumatic Stress, 7(2), 289-302.
Weathers, F., Litz, B. T., Herman, D., Huska, J., & Keane, T. (1993). The PTSD Checklist (PCL): Reliability, Validity, and Diagnostic Utility, Annual Convention of the International Society for Traumatic Stress Studies. San Antonio, TX.
Wilker, S., Pfeiffer, A., Elbert, T., Ovuga, E., Karabatsiakis, A., Krumbholz, A., Thieme, D., Schelling, G., & Kolassa, I. T. (2016). Endocannabinoid concentrations in hair are associated with PTSD symptom severity. Psychoneuroendocrinology, 67, 198-206.
Wirz, L., Reuter, M., Felten, A., & Schwabe, L. (2018). An endocannabinoid receptor polymorphism modulates affective processing under stress. Social cognitive and affective neuroscience, 13(11), 1177-1189.
Zhang, P.-W., Ishiguro, H., Ohtsuki, T., Hess, J., Carillo, F., Walther, D., Onaivi, E., Arinami, T., & Uhl, G. (2004). Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry, 9, 916-931.
Zuj, D. V., & Norrholm, S. D. (2019). The clinical applications and practical relevance of human conditioning paradigms for posttraumatic stress disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 88, 339-351.
Zuj, D. V., Palmer, M. A., Lommen, M. J., & Felmingham, K. L. (2016). The centrality of fear extinction in linking risk factors to PTSD: A narrative review. Neuroscience and Biobehavioral Reviews, 69, 15-35.
Zuj, D. V., Palmer, M. A., Malhi, G. S., Bryant, R., & Felmingam, K. L. (2017). Endogenous cortisol reactivity moderates the relationship between fear inhibition to safety signals and posttraumatic stress disorder symptoms. Psychoneuroendocrinology, 78, 14-21.